Product Description
Since last manyyears SaintroyLifescienceis leading manufacture, export and supplierofMelphalan Injection from Surat, Gujarat, India. Melphalan Injection Usedto treat multiple myeloma, ovarian cancer, melanoma, and AL amyloidosis.
Tags: Melphalan Injection manufacturer, Melphalan Injection exporter, Melphalan Injection supplier, and Melphalan Injection, whogmp approved Melphalan Injection manufacturer and supplier, Melphalan Injectiondistributor, Melphalan Injection shipper, Melphalan Injection 50 mg Melphalan Injection50 mgsupplier, Melphalan Injection50 mg.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility in Gujarat, India.
Registration: Saintroy Lifescienceis interested in registrationof own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country:Saintroy LifescienceMelphalan Injection export toUSA, Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal,Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile, Somalia, Philippines,Myanmar, Maldives, Thailand, Singapore, Malaysia, Hong Kong, China, Zimbabwe,Togo, Burkina Faso, Niger,Guinea Bissau, Congo, Democratic of republic, IvoryCosta, Oman, Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba,Colombia, Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran,Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Effective Cancer TherapyMelphalan Injection offers robust efficacy in treating multiple myeloma and ovarian cancer. Its established mechanism of action disrupts cancer cell growth, providing meaningful benefits for eligible patients. The product adheres to stringent quality standards, ensuring both safety and therapeutic value in clinical settings across India.
Convenient Single-Use PackagingEach Melphalan Injection comes in a secure, single-use glass vial along with a separate sterile diluent. This packaging ensures dose accuracy and sterility. The white to off-white freeze-dried powder form supports ease of reconstitution, facilitating prompt preparation when needed.
FAQ's of Melphalan Injection:
Q: How should Melphalan Injection be prepared before administration?
A: Reconstitute Melphalan Injection by mixing the freeze-dried powder with the supplied sterile diluent as per the instructions provided. The solution should be prepared immediately prior to intravenous administration to maintain sterility and efficacy.
Q: What conditions is Melphalan Injection typically used for?
A: This injection is primarily indicated for the treatment of multiple myeloma and ovarian cancer, as prescribed by a qualified healthcare professional.
Q: When should Melphalan Injection not be used?
A: Melphalan Injection is contraindicated in individuals with known hypersensitivity to melphalan. Always consult your physician about any allergies or medical conditions before starting therapy.
Q: Where should Melphalan Injection be stored to maintain its efficacy?
A: Store the vial in a cool and dry place, away from direct sunlight or heat, to ensure the medication's stability throughout its two-year shelf life.
Q: What is the recommended process for administering Melphalan Injection?
A: After reconstitution with the supplied diluent, Melphalan Injection should be administered intravenously by a trained healthcare professional in a controlled clinical environment.
Q: What are the benefits of using Melphalan Injection meeting IP or USP standards?
A: Compliance with Indian Pharmacopoeia or United States Pharmacopeia standards ensures that the product meets stringent safety and quality requirements, offering reliability and assurance to dealers, distributors, and healthcare providers.